Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cross-sectional Case-control Study on the Role of Endocrine Disruptors in Thyroid Cancer

NCT05747365 is registered in ClinicalTrials.gov with Istituto Auxologico Italiano as lead sponsor.

NCT NCT05747365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05747365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cross-sectional Case-control Study on the Role of Endocrine Disruptors in Thyroid Cancer
Lead sponsor
Istituto Auxologico Italiano
Phase
Observational
Overall status
Unknown status
Start date
July 12, 2022
Completion date
July 31, 2025
Enrollment
222 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endocrine disruptor chemicals, thyroid cancer